Forbes: Pharmacy Benefit Managers Are Not The Cause Of High Prescription Drug Prices
June 06, 2018
Blaming the system of rebates for high drug prices completely misdiagnoses the prescription drug market...
Drug Benefit Solutions is an educational platform explaining how pharmacy benefit managers (PBMs) reduce costs and improve quality on prescription drug benefits for consumers, employers, unions, and government programs.
Drug Benefit Solutions is a project of the Pharmaceutical Care Management Association (PCMA).
Recent News
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Highlights
- Biosimilars
- Drug Abuse Prevention
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Formulary Design
- Fraud
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- Specialty Pharmacies
- TRICARE
- Waste
The Pink Sheet: Part D Point-Of-Sale Rebates Losing Appeal? CBO Confirms Big Cost To Medicare
May 31, 2018
“This score strikes the third blow to the drug makers’ long-running, multi-million dollar campaign to shift blame for their own...
Politico: Health chief channels Trump’s combative approach on drug prices
May 30, 2018
“The rhetoric is loud because he really wants to put some pressure on industry to come up with some solutions,”...
May 23, 2018
Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by...
The New York Times: Trump Promises Lower Drug Prices, but Drops Populist Solutions
May 11, 2018
Mark Merritt said the real problem was the high prices set by drugmakers. “Getting rid of rebates and other price...
Forbes: Trump Doesn’t Know Who ‘Middlemen’ Are, But PBMs Okay With His Drug Price Agenda
May 11, 2018
“We support (the administration’s) call for greater flexibility in benefit design to encourage better price negotiations, including allowing Medicare Part D...
Bloomberg: Express Scripts Agrees to Ease Access to Costly Cholesterol Drug
May 01, 2018
The drugs became symbols of the nation’s rising drug prices after they were approved in 2015...
May 01, 2018
Sanofi and Regeneron have agreed to lower the price of their cholesterol medicine in exchange for easier access for patients...
Kaiser Health News: How A Drug Company Under Pressure For High Prices Ratchets Up Political Activity
April 30, 2018
Even including discounts, however, the company’s net profit margin for 2017 was 34 percent, its highest since at least 2000,...
USA Today: Drug copay groups: Critical patient charities or fronts for drug makers?
April 27, 2018
This practice, the HHS inspector general, could harm patients, the government and taxpayers because people might take pricey drugs instead...
Roll Call: Drug Pricing Proposal Should Revamp Medicare, GOP Experts Say
April 25, 2018
Moving reimbursement for those drugs into Part D could have a “massive impact overnight”...
Stat News: Drug makers question idea to shake up how Medicare pays for certain drugs
April 24, 2018
Drug manufacturers are pushing back against one of the administration’s major proposals to bring down drug prices...